UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of
the Securities Exchange Act of 1934
Date of Report: October 15, 2003
(Date of earliest event reported)
VASOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-18105 11-2871434
------------- ----------- ----------------------
(State or other jurisdiction of Commission (I.R.S. Employer
incorporation or organization) File Number) Identification Number)
180 Linden Avenue, Westbury, New York 11590
------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code (516) 997-4600
--------------
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
--------
99 Press release dated October 15, 2003 issued by Vasomedical, Inc.
("Registrant").
Item 9. Regulation FD Disclosure
The following information is furnished pursuant to Item 9, "Regulation FD
Disclosure" and Item 12, "Results of Operations and Financial Condition."
On October 15, 2003, the Registrant issued a press release announcing the
Registrant's financial results for its first fiscal quarter ended August 31,
2003. A copy of the Registrant's press release is attached hereto as Exhibit 99.
The information in this Form 8-K is being furnished under Item 9 and Item
12 and shall not be deemed to be "filed" for the purposes of Section 18 of the
Securities and Exchange Act of 1934 (the "Exchange Act"), or otherwise subject
to the liabilities of such section, nor shall such information be deemed
incorporated by reference in any filing under the Securities Act of 1933, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.
Signatures
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
VASOMEDICAL, INC.
By:/s/ Thomas W. Fry
-----------------------
Thomas W. Fry
Chief Financial Officer
Dated: October 16, 2003